Knut Pettersson
Directeur Technique/Scientifique/R&D chez Athera Biotechnologies AB
Provenance du réseau au premier degré de Knut Pettersson
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Knut Pettersson via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Iconic Therapeutics, Inc.
 Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
River Vision Development Corp.
 River Vision Development Corp. BiotechnologyHealth Technology River Vision Development Corp. develops novel protein therapies. The firm provides therapy for the treatment of graves orbitopathy which is a condition in which an autoimmune response is mounted against tissues behind the eye, causing inflammation, tissue proliferation and excess production of extracellular matrix. The company was founded in 2011 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Industrifonden
 Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Investment Managers | Consultant / Advisor | |
| Karolinska Institutet | College/University | Doctorate Degree | |
Vitamex AB
 Vitamex AB Pharmaceuticals: MajorHealth Technology Vitamex AB develops and manufactures pharmaceutical products. It is licensed to produce VMS products, nutraceuticals, OTC products, and Rx pharmaceuticals. The company manufactures cosmetics, anti-oxidants, minerals, and vitamins. Its products include drugs for anxiety, pain, cold & flu, indigestion, weight management, cardiovascular diseases, and hair, skin as well as nails-related problems. Vitamex was founded in 1986 and is headquartered in Norrköping, Sweden. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Royal Institute of Technology | College/University | Graduate Degree Graduate Degree | |
| International Institute for Management Development | College/University | Undergraduate Degree | |
| BioCrine AB | Director/Board Member | ||
Ernst & Young AB
 Ernst & Young AB Miscellaneous Commercial ServicesCommercial Services Ernst & Young AB provides tax advisory, auditing, and accounting services. It also offers support and advice on risk management, information technology security, and financial and business management. The company was founded in 1949 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| BONESUPPORT HOLDING AB | Medical Specialties | Director/Board Member | |
Acacia Pharma Ltd.
 Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| The European Society of Cardiology | Director/Board Member | ||
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Enterome SA
 Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member | |
| LIPIDOR AB | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
| KCIF Fund Management AB | Chief Executive Officer Chief Executive Officer | ||
| ASARINA PHARMA AB | Pharmaceuticals: Major | Public Communications Contact Comptroller/Controller/Auditor | |
Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt
 Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt Miscellaneous Commercial ServicesCommercial Services Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt is a non-profit organization based in Stockholm, Sweden. and has subsidiaries in Sweden. The organization's main objective is to raise funds for selected Swedish heart and lung research to help people live longer and healthier lives. The Swedish company works together with individuals and companies to collect and distribute funds for heart and lung research. The organization's vision is to create a world free from heart and lung disease. Kärlkramp, which is a temporary reduction of blood flow in the heart's coronary vessels and the main symptom is a squeezing chest pain, is one of the diseases they focus on. | Miscellaneous Commercial Services | Director/Board Member | |
Lundbeckfonden Ventures
 Lundbeckfonden Ventures Investment ManagersFinance Lundbeckfonden Ventures (Lundbeckfonden Ventures) is a venture capital firm wholly-owned by the Lundbeck Foundation. The firm was established in 2009 and is headquartered in Copenhagen, Denmark. | Investment Managers | Consultant / Advisor | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| INHALATION SCIENCES SWEDEN AB | Medical Specialties | Director of Finance/CFO Director of Finance/CFO | |
| KD Incentive AB | Director/Board Member Director/Board Member | ||
| MODUS THERAPEUTICS HOLDING AB | Biotechnology | Director/Board Member Director/Board Member | |
Ziarco Pharma Ltd.
 Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Biotechnology | Director/Board Member | |
| Flood Vision, Inc. | Director/Board Member | ||
BONE SUPPORT AB
 BONE SUPPORT AB Medical SpecialtiesHealth Technology BONE SUPPORT AB manufactures orthopedic supplies and equipment. Its products include cerament bone void filler, cerament G with gentamicin, cerament V with vancomycin. The company was founded by Lars Ake Alvar Lidgren in 1999 and is headquartered in Lund, Sweden. | Medical Specialties | Director/Board Member | |
Betagenon Sweden AB
 Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
SARomics Biostructures AB
 SARomics Biostructures AB BiotechnologyHealth Technology SARomics Biostructures AB provides protein three-dimensional structure determination and structure-based drug discovery services. The firm develops premium structural biology services. It offers crystallography services, which include crystallization screen and structure determination, nuclear magnetic resonance spectroscopy services, such as ligand binding assays/fragment screening, structure determination, and verification of the structural integrity of target protein, gene-to-structure services, such as protein cloning, expression, purification, and structure determination, kinase structures and kinobits, which include pre-made complexes of kinases with small-molecule fragments to serve as a starting point in a discovery project, structure-based drug discovery services, such as hit identification, hit optimization, and lead generation, gene-to lead services, including a combination of gene-to-structure and structure-based drug discovery, and structure-activity protein optimization services. The company was founded by Björn Ulrik Walse, Sven Anders Mikael Akke, Derek W. Logan, Salam Al-Karadaghi, and Bo Svensson in 2006 and is headquartered in Lund, Sweden. | Biotechnology | Director/Board Member | |
| INFANT BACTERIAL THERAPEUTICS AB | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
| RENEO PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| ACACIA PHARMA GROUP PLC | Pharmaceuticals: Other | Director/Board Member | |
| CERENO SCIENTIFIC AB | Pharmaceuticals: Major | Director/Board Member | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Chief Executive Officer | |
| M. Owens Management Consulting AB | Director/Board Member | ||
| ZICCUM AB | Medical Specialties | Corporate Officer/Principal Director of Finance/CFO | |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| Sound Biotech ApS | Chief Executive Officer | ||
Curzion Pharmaceuticals, Inc.
 Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
| ONCOZENGE AB | Pharmaceuticals: Major | Director of Finance/CFO | |
| Olsson Solutions AB | Director/Board Member | ||
| Lecra AB | Director/Board Member | ||
Sound Bioventures Management AB
 Sound Bioventures Management AB Investment ManagersFinance Sound Bioventures Management AB is a venture capital firm founded in 2021 by Casper Breum, Johan Kordel and Bibhash Mukhopadhyay. The firm is headquartered in Malmo, Sweden. | Investment Managers | Founder | |
| Medinvest AB | Private Equity Investor | ||
| Betagenon Bio AB | Director/Board Member Chairman | ||
Amplifier TX AB
 Amplifier TX AB BiotechnologyHealth Technology Part of Cambrian BioPharma, Inc., Amplifier TX AB is a Swedish biopharmaceutical company that develops clinical molecule AMPK activators. The private company is based in Umeå, Sweden. The company was founded in 2023 by Thomas Edlund, Helena Edlund. James Hall has been the CEO of the company since 2023. | Biotechnology | Director/Board Member Chief Executive Officer |
Statistiques
Internationale
| Suède | 34 |
| Etats-Unis | 8 |
| Royaume-Uni | 5 |
| France | 4 |
| Danemark | 3 |
Sectorielle
| Health Technology | 27 |
| Commercial Services | 7 |
| Finance | 5 |
| Consumer Services | 4 |
Opérationnelle
| Director/Board Member | 76 |
| Corporate Officer/Principal | 21 |
| Director of Finance/CFO | 13 |
| Chief Executive Officer | 12 |
| Chairman | 10 |
Relations les plus connectées
- Bourse
- Insiders
- Knut Pettersson
- Connexions Sociétés